Skip to main content
. 2019 Jul 1;142(8):2182–2197. doi: 10.1093/brain/awz181

Table 1.

Summary of the features of the studies included in the review

Neurotechnology Total studies found Number of studies retained Number of patients Patient population Mean difference in upper limb FM pre-post intervention (min–max) Number of sessions (min–max)
General - 4 59 186 - - -
Robotics 38 8 1612 Subacute–chronic 2.0–18.0 10–40
Moderate–severe
Electrical stimulation 38 11 1296 Acute–subacute–chronic 4.9–14.8 10–120
Moderate–severe
Invasive brain stimulation 10 2 94 Chronic–moderate–severe 4.3–10.0 15–30
tDCs 42 14 1334 Acute–subacute–chronic 5.2–11.4 2–200
Moderate–severe
TMS 9 6 648 Subacute–chronic 3.0–13.7 1–100
Mild–moderate–severe
BCI/BMI 13 10 823 Subacute–chronic 6.3–13.2 1–30
Moderate–severe
tDCs + robotics 55 5 295 Subacute–chronic 3.0–10.3 10–30
Moderate–severe
Electrical stimulation + robotics 55 2 50 Chronic–moderate 3.9–11.0 20
Electrical stimulation + TMS/tDCs 55 3 60 Acute–subacute–chronic 4.3–12.7 5–24
Moderate–severe
BCI/BMI + tDCs + robotics 52 2 37 Chronic 5.0–6.0 10
Moderate–severe

The upper limb FM score is between 0 and 66. Min = minimum; max = maximum.